scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Thomas Hieronymus | |
Zsofia Sagi | |||
P2860 | cites work | Interplay between scatter factor receptors and B plexins controls invasive growth | Q24295561 |
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
Activation of the zymogen of hepatocyte growth factor activator by thrombin | Q24318554 | ||
The protein kinase complement of the human genome | Q24324497 | ||
Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper | Q24678698 | ||
Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation | Q27320214 | ||
Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
The semaphorin 4D receptor controls invasive growth by coupling with Met | Q28219215 | ||
Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ | Q71120773 | ||
Partial characterization of a hepatocyte growth factor from rat platelets | Q71327547 | ||
Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture | Q72075540 | ||
Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis | Q73126057 | ||
Hepatocyte growth factor is a regulator of monocyte-macrophage function | Q73365858 | ||
Hepatocyte growth factor-stimulated invasiveness of monocytes | Q73877053 | ||
The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice | Q74455262 | ||
Expression and function of c-Met, a receptor for hepatocyte growth factor, during T-cell development | Q74586546 | ||
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin | Q77995830 | ||
Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice | Q81386359 | ||
GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response | Q81491673 | ||
Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver | Q82556836 | ||
Dermal fibroblasts promote the migration of dendritic cells | Q84474126 | ||
β-Catenin promotes the differentiation of epidermal Langerhans dendritic cells | Q85883913 | ||
Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2 | Q86600568 | ||
Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | Q87551135 | ||
Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells. | Q50623825 | ||
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. | Q52886970 | ||
The role of SF/HGF and c-Met in the development of skeletal muscle. | Q52980024 | ||
Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis. | Q53357929 | ||
Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. | Q53778646 | ||
Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity. | Q54593030 | ||
HGF/Met-Signaling Contributes to Immune Regulation by Modulating Tolerogenic and Motogenic Properties of Dendritic Cells. | Q55009988 | ||
Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met | Q58324027 | ||
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats | Q60034429 | ||
Phorbol ester-induced secretion of human hepatocyte growth factor by human skin fibroblasts and its inhibition by dexamethasone | Q67593759 | ||
Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells | Q67919319 | ||
Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells | Q70911182 | ||
Met, metastasis, motility and more | Q28235183 | ||
Invasive growth: a MET-driven genetic programme for cancer and stem cells | Q28253680 | ||
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor | Q28307227 | ||
Differential responsiveness of cord and adult blood monocytes to hepatocyte growth factor | Q28347515 | ||
The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs | Q28363959 | ||
Scatter factor/hepatocyte growth factor is essential for liver development | Q28504542 | ||
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud | Q28506228 | ||
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II | Q30498266 | ||
Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo | Q30513354 | ||
Serial analysis of gene expression in human monocyte-derived dendritic cells | Q30741965 | ||
Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein | Q33324580 | ||
External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers | Q33590480 | ||
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Q33778883 | ||
Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding | Q33938013 | ||
Regulatory activity of autocrine IL-10 on dendritic cell functions | Q33938563 | ||
Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor | Q34267718 | ||
Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. | Q34379859 | ||
Boolean approach to signalling pathway modelling in HGF-induced keratinocyte migration | Q34409663 | ||
Scatter-factor and semaphorin receptors: cell signalling for invasive growth | Q34632043 | ||
Showering c-MET-dependent cancers with drugs | Q34769397 | ||
Drug development of MET inhibitors: targeting oncogene addiction and expedience | Q34782774 | ||
Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function | Q34963286 | ||
How to make tubes: signaling by the Met receptor tyrosine kinase | Q35147372 | ||
A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells | Q35213426 | ||
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease | Q35605610 | ||
Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma | Q35630012 | ||
CD44 is required for two consecutive steps in HGF/c-Met signaling. | Q35805198 | ||
Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration | Q36069078 | ||
MET is required for the recruitment of anti-tumoural neutrophils | Q36125652 | ||
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis | Q36235637 | ||
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration | Q36384618 | ||
New signals from the invasive front | Q36488744 | ||
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP) | Q36704207 | ||
Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. | Q36762650 | ||
Met provides essential signals for liver regeneration | Q36987592 | ||
Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo | Q37733681 | ||
MET signalling: principles and functions in development, organ regeneration and cancer | Q37811895 | ||
Hepatocyte growth factor twenty years on: Much more than a growth factor | Q37825664 | ||
Targeting MET in cancer: rationale and progress | Q37978193 | ||
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs | Q38083976 | ||
The clash of Langerhans cell homeostasis in skin: Should I stay or should I go? | Q38194815 | ||
Mechanisms regulating skin immunity and inflammation | Q38203783 | ||
Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Q38283419 | ||
Hepatocyte growth factor and Met in drug discovery | Q38377273 | ||
Antigen-Presenting Cells in the Skin | Q39146789 | ||
c-Met is essential for wound healing in the skin | Q39735911 | ||
Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells | Q40243630 | ||
c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74. | Q40472507 | ||
A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth | Q40765252 | ||
Emerging multipotent aspects of hepatocyte growth factor | Q41066829 | ||
Hepatocyte growth factor specifically binds to sulfoglycolipids | Q41476038 | ||
Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. | Q41543722 | ||
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin | Q41578917 | ||
TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts | Q41605256 | ||
Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway | Q41903686 | ||
The small G protein Arf6 expressed in keratinocytes by HGF stimulation is a regulator for skin wound healing. | Q42028035 | ||
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
The impact of c-met/scatter factor receptor on dendritic cell migration | Q44062597 | ||
The HGF receptor/Met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity. | Q44274081 | ||
Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin. | Q44459039 | ||
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model | Q45154742 | ||
Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts | Q45164797 | ||
Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
Dendritic cell function in mice lacking Plexin C1. | Q46557692 | ||
A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function | Q47724235 | ||
Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes. | Q48334272 | ||
Langerhans cells and lymph node dendritic cells express the tight junction component claudin-1. | Q48910439 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | cell | Q7868 |
growth factor receptor | Q118226 | ||
membrane protein | Q423042 | ||
integumentary system | Q483213 | ||
enzyme | Q8047 | ||
cell surface receptor | Q2476074 | ||
proto-oncogene protein | Q66020913 | ||
neoplasm protein | Q66894191 | ||
hemic and immune systems | Q70202933 | ||
P304 | page(s) | 517 | |
P577 | publication date | 2018-03-16 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | The Impact of the Epithelial-Mesenchymal Transition Regulator Hepatocyte Growth Factor Receptor/Met on Skin Immunity by Modulating Langerhans Cell Migration. | |
P478 | volume | 9 |
Q60920855 | HGF/c-MET Signaling in Melanocytes and Melanoma |
Q92344290 | Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy |
Q91997148 | c-Met as a new marker of cellular senescence |
Search more.